← Eichor
Condition: Attr Cm Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Attr Cm

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Phase 4 · 16 location(s) · Alexion Pharmaceuticals, Inc. · NCT07306949Prospective Evaluation of Artificial Intelligence-enabled Screening for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
Phase N/A · 1 location(s) · Yale University · NCT07398950CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in Peop
Phase 3 · 292 location(s) · Novo Nordisk A/S · NCT07207811A Research Study to Look at the Distribution and Effects of Coramitug on Amyloid Deposits in Heart Tissue Using PET/CT I
Phase 1 · 1 location(s) · Novo Nordisk A/S · NCT07448623Thailand ATTR-CM Registry
Phase N/A · 8 location(s) · Mahidol University · NCT06338696TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Phase 3 · 240 location(s) · Alnylam Pharmaceuticals · NCT07052903MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Phase 3 · 132 location(s) · Intellia Therapeutics · NCT06128629A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability,
Phase 1/Phase 2 · 3 location(s) · YolTech Therapeutics Co., Ltd · NCT06539208Determining the Association of TTR Stabilizing Therapy With Circulating TTR Amyloid Aggregates Over Time in Patients Wit
Phase N/A · 1 location(s) · University of Texas Southwestern Medical Center · NCT07196839Haemodynamic Effects of Dobutamine in Patients With Wild-type Transthyretin Amyloid Cardiomyopathy (ATTRwt)
Phase 1/Phase 2 · 1 location(s) · Steen Hvitfeldt Poulsen · NCT06318260Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
NA · 1 location(s) · Dominik Benz · NCT07112066US Benchmarking Clinical Study
Phase N/A · 3 location(s) · eMyosound SAS · NCT07215715A Study to Learn About the Use of Acoramidis in Patients With a Heart Condition Called Transthyretin Amyloid Cardiomyopa
Phase N/A · 1 location(s) · Bayer · NCT07235462A Study to Learn More About the Change in the Blood Levels of Transthyretin When Participants With Transthyretin Amyloid
Phase 4 · 20 location(s) · Bayer · NCT07298044Clinical Study of ATTR-CM
Phase 4 · 1 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT04935021DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting
Phase N/A · 4 location(s) · Alnylam Pharmaceuticals · NCT07358078Phenotyping and Characterization of wtATTR-CM (TRACE 1)
Phase N/A · 1 location(s) · Steen Hvitfeldt Poulsen · NCT06291805OverTTuRe: Characteristics, Treatment Patterns and Outcomes of Patients With ATTR Amyloidosis
Phase N/A · 29 location(s) · AstraZeneca · NCT06355934Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Phase N/A · 82 location(s) · AstraZeneca · NCT06465810Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk Popu
NA · 48 location(s) · AstraZeneca · NCT07338942A Multicenter Study on Atrioventricular Regurgitation in Transthyretin Amyloid Cardiomyopathy: Definition, Prevalence, a
Phase N/A · 8 location(s) · Medical University of Vienna · NCT06836011Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Patho
Phase 3 · 103 location(s) · Eidos Therapeutics, a BridgeBio company · NCT06563895Quantitative-imaging in Cardiac Transthyretin Amyloidosis
Phase N/A · 1 location(s) · University of Edinburgh · NCT05776212
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.